DePuy Orthopaedics Newswire (Page 5)

DePuy Orthopaedics Newswire (Page 5)

Comprehensive Real-Time News Feed for DePuy Orthopaedics. (Page 5)

Results 81 - 100 of 1,152 in DePuy Orthopaedics

  1. Common morning sickness drug may not workRead the original story w/Photo

    Jan 4, 2017 | Reuters

    ... A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. ...

    Comment?

  2. Even after noncardiac surgery, heart attacks and strokes may be a riskRead the original story w/Photo

    Jan 4, 2017 | Reuters

    ... A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. ...

    Comment?

  3. France orders massive duck cull to contain bird fluRead the original story w/Photo

    Jan 4, 2017 | Reuters

    ... A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. ...

    Comment?

  4. Judge Halves $1 Billion Award in J&J Hip Implants CaseRead the original story w/Photo

    Jan 4, 2017 | News Max

    A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. U.S. District Judge Ed Kinkeade in Dallas cited "constitutional considerations" that limit how much plaintiffs may recover in punitive damages but upheld the jury's findings that the implants were defectively designed and that the companies failed to warn consumers about the risks.

    Comment?

  5. Slovenia confirms first case of H5N8 bird fluRead the original story w/Photo

    Jan 4, 2017 | Reuters

    ... A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. ...

    Comment?

  6. Huge Johnson & Johnson Damage Award Slashed by HalfRead the original story w/Photo

    Jan 4, 2017 | TheStreet.com

    Johnson & Johnson's $1 billion damages award in hip implant lawsuits against the company was halved by a U.S. judge late Tuesday. The company, which faced the possibility of a $1 billion payout to plaintiffs in six lawsuits against its DePuy Orthopaedics division for faulty hip implants, now owes damages of a little more than $500 million, according to U.S. District Judge Ed Kinkeade in Dallas.

    Comment?

  7. Judge Halves Jury's $1 Billion Punitive Damages Award in J&J Hip Implant CaseRead the original story w/Photo

    Jan 4, 2017 | Insurance Journal West

    ... aintiffs, Lanier said. The plaintiffs are appealing the reductions, he added. The lead case is Andrews v. DePuy Orthopaedics Inc., 15-cv-03484, U.S. District Court, Northern District of Texas (Dallas)

    Comment?

  8. Judge halves $1-billion award in J&J hip implants caseRead the original story w/Photo

    Jan 4, 2017 | The Globe and Mail

    A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1-billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. U.S. District Judge Ed Kinkeade in Dallas cited "constitutional considerations" that limit how much plaintiffs may recover in punitive damages but upheld the jury's findings that the implants were defectively designed and that the companies failed to warn consumers about the risks.

    Comment?

  9. Chevron resumes operation at Gorgon LNG train 1 after month-long outageRead the original story w/Photo

    Jan 3, 2017 | Reuters

    ... 3 A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. * ...

    Comment?

  10. U.S. office vacancy rate falls in fourth quarter - ReisRead the original story w/Photo

    Jan 3, 2017 | Reuters

    ... 3 A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy's Pinnacle hip implants. * ...

    Comment?

  11. Johnson & Johnson (JNJ) is National Pension Service's 6th Largest PositionRead the original story w/Photo

    Dec 27, 2016 | IntersportsWire

    National Pension Service raised its position in shares of Johnson & Johnson by 8.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 1,627,070 shares of the company's stock after buying an additional 131,498 shares during the period.

    Comment?

  12. Factory Mutual Insurance Co. Lowers Position in Johnson & JohnsonRead the original story w/Photo

    Dec 27, 2016 | IntersportsWire

    Factory Mutual Insurance Co. lowered its stake in shares of Johnson & Johnson by 0.7% during the third quarter, according to its most recent disclosure with the SEC.

    Comment?

  13. Swiss stocks - Factors to watch on Dec 26Read the original story w/Photo

    Dec 26, 2016 | Reuters

    Dec 27 The Swiss blue-chip SMI was seen opening 0.1 percent higher at 8,241 points on Tuesday, according to premarket indications by bank Julius Baer . The SIX Swiss Exchange said U.S. hedge fund founder Dan Och, of Och-Ziff Capital Management Group, through a variety of investment vehicles holds more than 3.1 percent of shares in Swiss biotech Actelion that is being courted by possible buyers including Johnson & Johnson.

    Comment?

  14. Johnson & Johnson (JNJ) Stake Cut by Cornerstone Investment Partners LLCRead the original story w/Photo

    Dec 26, 2016 | IntersportsWire

    Cornerstone Investment Partners LLC lowered its position in Johnson & Johnson by 23.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission . The institutional investor owned 981,789 shares of the company's stock after selling 308,804 shares during the period.

    Comment?

  15. 3 Big Pharma Stocks With the Fastest-Growing DividendsRead the original story w/Photo

    Dec 25, 2016 | The Motley Fool

    Hockey great Wayne Gretzsky famously said: "I skate to where the puck is going to be, not where it has been." I think the concept definitely applies to investing in dividend stocks.

    Comment?

  16. Johnson & Johnson (JNJ) Shares Bought by Ariel Capital Advisors LLCRead the original story w/Photo

    Dec 24, 2016 | Daily Political

    Ariel Capital Advisors LLC boosted its stake in Johnson & Johnson by 2.8% during the third quarter, Holdings Channel reports. The institutional investor owned 27,130 shares of the company's stock after buying an additional 739 shares during the period.

    Comment?

  17. Market study on expected growth Biomaterials Market by 2024Read the original story

    Dec 24, 2016 | Emailwire.com

    ... are: Angiotech Pharmaceuticals Inc., Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), DENTSPLY International, Inc. (U.S.), Orthovita, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), Invibio Ltd. ...

    Comment?

  18. Johnson & Johnson (JNJ) Position Lowered by Investment Management of Virginia LLCRead the original story w/Photo

    Dec 23, 2016 | IntersportsWire

    Investment Management of Virginia LLC cut its position in shares of Johnson & Johnson by 1.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 37,924 shares of the company's stock after selling 625 shares during the period.

    Comment?

  19. It's Official, Johnson & Johnson's Management Has Lost Its MindRead the original story w/Photo

    Dec 23, 2016 | The Motley Fool

    A little more than one week ago, healthcare conglomerate Johnson & Johnson announced that it was no longer pursuing Swiss-based lung disease drug specialist Actelion . Johnson & Johnson had initially approached Actelion in late November with an offer worth about $26 billion to acquire the maker of therapies to treat pulmonary arterial hypertension , a disease characterized by high blood pressure between the heart and lungs.

    Comment?

  20. Actelion Re-Enters Talks With J&J, Sidelining SanofiRead the original story

    Dec 23, 2016 | NACD

    "Actelion has turned back to prospective bidder Johnson & Johnson for exclusive talks about a 'strategic transaction,'" confirms CNBC News , "in an about-turn that appears to sideline rival suitor Sanofi." The Swiss biotech company wrote in a brief statement released late Wednesday that it was in exclusive talks with the U.S. healthcare giant but that there could be "no assurance any transaction will result from these discussions."

    Comment?